Data / Drug companies / Dorzolamide hydrochloride and timolol maleate
Dorzolamide hydrochloride and timolol maleate: 11 companies and 14 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Dorzolamide hydrochloride and timolol maleate is listed in the FDA National Drug Code Directory by 11 companies, with 14 products in commercial distribution. 11 of the products (78.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution/ drops; solution, and the newest product started marketing on May 2, 2023.
The request: Get every company that lists dorzolamide hydrochloride and timolol maleate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 11
- Products
- 14
- Generic (ANDA) products
- 11 (78.6%)
- Application numbers
- 9
- Routes
- Ophthalmic
- Brand names
- Cosopt PF, Cosopt
- openFDA record search
- api.fda.gov
Companies that list dorzolamide hydrochloride and timolol maleate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 3 | solution/ drops; solution | Generic drugs (ANDA) | June 15, 2020 |
| Thea Pharma Inc. | 2 | solution/ drops | New drug applications (NDA) | December 10, 2022 |
| A-S Medication Solutions | 1 | solution/ drops | Generic drugs (ANDA) | July 14, 2009 |
| Akorn | 1 | solution/ drops | New drug applications (NDA) | February 1, 2019 |
| Aurobindo Pharma Limited | 1 | solution/ drops | Generic drugs (ANDA) | May 14, 2021 |
| Bausch & Lomb Incorporated | 1 | solution/ drops | Generic drugs (ANDA) | July 14, 2009 |
| Gland Pharma Limited | 1 | solution/ drops | Generic drugs (ANDA) | September 19, 2022 |
| Ingenus Pharmaceuticals, LLC | 1 | solution/ drops | Generic drugs (ANDA) | May 2, 2023 |
| Micro Labs Limited | 1 | solution/ drops | Generic drugs (ANDA) | June 15, 2020 |
| Sandoz Inc | 1 | solution | Generic drugs (ANDA) | January 2, 2010 |
| Somerset Therapeutics, LLC | 1 | solution | Generic drugs (ANDA) | June 25, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution/ drops | 11 | 78.6% |
| Solution | 3 | 21.4% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 11 | 78.6% |
| New drug applications (NDA) | 3 | 21.4% |
Pharmacologic classes
| Class | Products |
|---|---|
| Carbonic Anhydrase Inhibitor | 14 |
| beta-Adrenergic Blocker | 14 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.